RJT
AGN

Raymond James Trust’s Allergan plc AGN Stock Holding History

Raymond James Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,198
Closed -$389K – 960
2020
Q1 		$389K Sell
2,198
-1,365
-38% -$257K 0.02% 464
2019
Q4 		$681K Sell
3,563
-903
-20% -$163K 0.03% 394
2019
Q3 		$752K Buy
4,466
+59
+1% +$9.61K 0.04% 360
2019
Q2 		$738K Sell
4,407
-816
-16% -$113K 0.04% 350
2019
Q1 		$765K Sell
5,223
-230
-4% -$33.3K 0.04% 333
2018
Q4 		$729K Sell
5,453
-870
-14% -$143K 0.05% 310
2018
Q3 		$1.2M Buy
6,323
+591
+10% +$109K 0.07% 247
2018
Q2 		$956K Sell
5,732
-258
-4% -$41.4K 0.06% 278
2018
Q1 		$1.01M Buy
5,990
+1,345
+29% +$226K 0.07% 243
2017
Q4 		$760K Sell
4,645
-3,985
-46% -$715K 0.05% 296
2017
Q3 		$1.77M Sell
8,630
-274
-3% -$63.7K 0.13% 177
2017
Q2 		$2.16M Buy
8,904
+36
+0.4% +$8.46K 0.16% 138
2017
Q1 		$2.12M Buy
8,868
+629
+8% +$146K 0.16% 135
2016
Q4 		$1.73M Buy
8,239
+1,903
+30% +$394K 0.14% 162
2016
Q3 		$1.46M Sell
6,336
-414
-6% -$101K 0.13% 167
2016
Q2 		$1.56M Sell
6,750
-260
-4% -$59.9K 0.14% 157
2016
Q1 		$1.88M Sell
7,010
-466
-6% -$133K 0.18% 129
2015
Q4 		$2.34M Buy
7,476
+256
+4% +$76.2K 0.22% 109
2015
Q3 		$1.96M Buy
+7,220
New +$2.22M 0.22% 105
2015
Q2 		– Sell
-7,970
Closed -$2.37M – 658
2015
Q1 		$2.37M Buy
+7,970
New +$2.27M 0.25% 94

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Raymond James Trust's AGN Position: Q2 2020 in Review

Raymond James Trust sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,198 shares — an estimated $389K sold.

Raymond James Trust first reported a position in AGN in Q1 2015 and held it in 20 quarters. The position peaked at $2.37M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Raymond James Trust reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Raymond James Trust sold 2,198 Allergan plc shares in Q2 2020, an estimated $389K.
  • Raymond James Trust first reported a position in Allergan plc in Q1 2015 and held it in 20 quarters.
  • Raymond James Trust's Allergan plc position peaked at $2.37M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Raymond James Trust's 13F filing for Q2 2020, filed 16 Jul 2020.